Home › Glioma › Connecticut
Glioma clinical trials in Connecticut
6 studies for Glioma are looking for participants at sites in Connecticut.
Cities in Connecticut
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
- Connecticut Children's Medical Center, Hartford
- Yale University, New Haven
RecruitingPhase 1/2
12 Months – 21 Years · All sexes · Updated Oct 1, 2026 · NCT05099003Language Network Prehab Via fMRI Neurofeedback
- Yale School of Medicine, New Haven
Recruiting
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07488780Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- Yale Cancer Center, New Haven
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07326566SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- Yale University, New Haven
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 28, 2026 · NCT05303519A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Norwalk Hospital, Norwalk
RecruitingPhase 2
Ages 8 and older · All sexes · Updated Jul 27, 2026 · NCT05503797Pembrolizumab, Olaparib, and Temozolomide for People With Glioma
- Hartford Healthcare Alliance (Data Collection Only), Hartford
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 22, 2026 · NCT05188508From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.